Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach 296 million people worldwide.
A grandfather and grandson hugging

Our purpose


Reimagine medicine to improve and extend people's lives.

A family standing outside looking into the sunset

Our vision
 

Become the most valued and trusted medicines company in the world.

Group of women from an indigenous community at a health workshop near Santa Cecilia, Colombia

Our strategy
 

Deliver high value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Our footprint

77k
Employees
118
Countries with products sold
304m
Patients reached*
Download the Report on Nonfinancial Matters 2025 for more details (PDF 1.0 MB)
Child having medical examination

Bringing breakthroughs to more patients

Ensuring people everywhere can benefit from the latest medical breakthroughs is a shared global responsibility.

Learn more

We focus on core therapeutic areas with high unmet patient needs

A healthcare professional and senior patient in a conversation using a tablet

Cardiovascular, renal and metabolic

Transforming how the world tackles cardiovascular disease and delivering new treatments for people with chronic kidney diseases.
A healthcare professional taking the blood pressure of a female patient

Immunology

Working to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
A nurse and patient engaged in a hug

Neuroscience

Committed to change the course of disease progression in neuroscience.
A doctor and patient discussing medical results on a tablet

Oncology

Combining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.

and technology platforms that enable cutting-edge innovative therapies

Orange gradient icon of a flask

Chemistry

Chemistry is the discovery of low molecular weight synthetic molecules that can be optimized as medicines.
Orange gradient icon of an antibody

Biotherapeutics

Biotherapeutics, or biologics, are medicines derived from the molecules of life, carefully engineered to treat specific diseases.
Orange gradient icon of a syringe

xRNA

RNA therapies use various forms of ribonucleic acids (RNA) to modify biological pathways in the body to treat or cure specific illnesses.
Orange gradient icon of an atom

Radioligand therapy

Radioligand therapy delivers precision-targeted radiation to cancer cells in the body with the goal of limiting damage to surrounding tissue.
Orange gradient icon of a gene

Gene and cell therapy

Gene therapies modify part of a patient’s genetic makeup to help treat genetic or inherited diseases. Cell therapies treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body.


 

In this new era, we’re ready.
Together, let’s reimagine medicine to improve and extend people’s lives.

 

Resource links

Pipeline
Impact
Leadership

*Number of patients reached with medicines registered and commercialized by Novartis globally, including established medicines